Ophthotech Corporation Company Profile (NASDAQ:OPHT)

About Ophthotech Corporation

Ophthotech Corporation logoOphthotech Corporation is a biopharmaceutical company. The Company specializes in the development of therapeutics to treat diseases of the back of the eye, with a focus on developing therapeutics for age-related macular degeneration (AMD). Its advanced product candidate is Fovista, which is for use in combination with anti-vascular endothelial growth factor (VEGF) drugs. It is also developing its product candidate Zimura for the treatment of patients with geographic atrophy, a form of dry AMD, in combination with VEGF therapy for the treatment of polypoidal choroidal vasculopathy (PCV). Fovista is being tested in Phase III clinical development. In addition, it has initiated additional clinical trials to evaluate the potential additional benefits of Fovista administered in combination with anti-VEGF drugs in wet AMD patients, known as Fovista Expansion Studies. Zimura has completed a small, multicenter, uncontrolled, open label Phase I/IIa clinical trial.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: OPHT
  • CUSIP:
Key Metrics:
  • Previous Close: $4.26
  • 50 Day Moving Average: $4.63
  • 200 Day Moving Average: $30.16
  • 52-Week Range: $4.19 - $65.96
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.12
  • P/E Growth: 0.00
  • Market Cap: $152.07M
  • Outstanding Shares: 35,697,000
  • Beta: 1.85
Profitability:
  • Net Margins: -323.19%
  • Return on Equity: -916.07%
  • Return on Assets: -41.63%
Debt:
  • Current Ratio: 6.07%
  • Quick Ratio: 6.07%
Additional Links:
Companies Related to Ophthotech Corporation:

Analyst Ratings

Consensus Ratings for Ophthotech Corporation (NASDAQ:OPHT) (?)
Ratings Breakdown: 12 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $59.11 (1,287.58% upside)

Analysts' Ratings History for Ophthotech Corporation (NASDAQ:OPHT)
Show:
DateFirmActionRatingPrice TargetDetails
12/13/2016GabelliDowngradeBuy -> HoldView Rating Details
12/13/2016Morgan StanleyDowngradeOverweight -> Equal WeightView Rating Details
12/12/2016Goldman Sachs Group, Inc. (The)UpgradeSell -> NeutralView Rating Details
12/12/2016Leerink SwannDowngradeOutperform -> Market PerformView Rating Details
12/12/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details
12/12/2016BTIG ResearchDowngradeBuy -> NeutralView Rating Details
12/12/2016Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details
12/12/2016Citigroup Inc.DowngradeBuy -> NeutralView Rating Details
12/12/2016Barclays PLCDowngradeOverweight -> Equal WeightView Rating Details
12/12/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$11.00View Rating Details
12/12/2016SunTrust Banks, Inc.DowngradeBuy -> HoldView Rating Details
12/12/2016Chardan CapitalDowngradeBuy -> Neutral$15.00View Rating Details
11/19/2015Oppenheimer Holdings, Inc.Reiterated RatingOutperform$95.00View Rating Details
(Data available from 2/24/2015 forward)

Earnings

Earnings History for Ophthotech Corporation (NASDAQ:OPHT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2017Q4 2016($1.72)$5.26 millionN/AView Earnings Details
11/8/2016Q316($1.64)($1.71)$6.20 million$1.67 millionViewListenView Earnings Details
8/3/2016Q216($1.05)($0.85)$18.64 million$28.20 millionViewListenView Earnings Details
5/4/2016Q116($1.33)($1.03)$7.22 million$15.70 millionViewListenView Earnings Details
2/24/2016Q415($1.35)($1.02)$7.59 million$4.78 millionViewListenView Earnings Details
11/5/2015Q315($0.98)($1.14)$11.31 million$3.40 millionViewN/AView Earnings Details
8/5/2015Q215($1.02)($1.08)$2.77 million$1.60 millionViewN/AView Earnings Details
5/11/2015Q115($0.75)$0.22$3.68 million$41.70 millionViewListenView Earnings Details
2/23/2015Q414($0.57)($1.06)$12.36 million$1.68 millionViewN/AView Earnings Details
11/11/2014Q314($0.62)$0.31$8.02 million$39.58 millionViewN/AView Earnings Details
8/6/2014Q214($0.56)($1.57)$4.31 millionViewN/AView Earnings Details
5/13/2014Q1($0.67)($0.64)ViewListenView Earnings Details
2/27/2014($0.50)($0.65)ViewN/AView Earnings Details
11/13/2013Q313($1.00)($10.26)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Ophthotech Corporation (NASDAQ:OPHT)
Current Year EPS Consensus Estimate: $-5.28 EPS
Next Year EPS Consensus Estimate: $-3.79 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164($1.50)($1.35)($1.43)
Q2 20163($1.24)($0.66)($0.89)
Q3 20162($1.62)($1.58)($1.60)
Q4 20162($1.76)($1.74)($1.75)
Q1 20171($1.51)($1.51)($1.51)
Q2 20171($1.30)($1.30)($1.30)
Q3 20171($0.69)($0.69)($0.69)
Q4 20171($0.37)($0.37)($0.37)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Ophthotech Corporation (NASDAQ:OPHT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Ophthotech Corporation (NASDAQ:OPHT)
Insider Ownership Percentage: 2.00%
Institutional Ownership Percentage: 95.66%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/5/2017David R GuyerCEOSell3,785$4.96$18,773.60View SEC Filing  
1/5/2017Henric Bjorn BjarkeSVPSell316$4.96$1,567.36View SEC Filing  
1/5/2017Samir Chandrakant PatelPresidentSell3,844$4.96$19,066.24View SEC Filing  
1/3/2017Barbara A WoodSVPSell675$4.90$3,307.50View SEC Filing  
1/3/2017David R GuyerCEOSell3,484$4.90$17,071.60View SEC Filing  
1/3/2017Samir Chandrakant PatelPresidentSell2,999$4.90$14,695.10View SEC Filing  
12/23/2016Barbara A. WoodSVPSell746$4.92$3,670.32View SEC Filing  
12/22/2016Glenn SblendorioCFOSell1,079$4.85$5,233.15View SEC Filing  
12/15/2016A/S NovoMajor ShareholderSell3,610,487$4.87$17,583,071.69View SEC Filing  
11/1/2016David R GuyerCEOSell22,060$35.61$785,556.60View SEC Filing  
10/3/2016David R GuyerCEOSell22,060$44.37$978,802.20View SEC Filing  
9/29/2016Samir Chandrakant PatelPresidentSell20,000$55.17$1,103,400.00View SEC Filing  
8/29/2016Samir Chandrakant PatelPresidentSell20,000$52.80$1,056,000.00View SEC Filing  
8/1/2016David R GuyerCEOSell24,060$64.47$1,551,148.20View SEC Filing  
7/29/2016Samir Chandrakant PatelPresidentSell20,000$64.21$1,284,200.00View SEC Filing  
7/1/2016David R GuyerCEOSell24,060$52.12$1,254,007.20View SEC Filing  
6/30/2016Samir Chandrakant PatelPresidentSell41,846$51.23$2,143,770.58View SEC Filing  
6/3/2016Axel BolteDirectorBuy3,500$56.97$199,395.00View SEC Filing  
6/2/2016Glenn SblendorioCFOSell671$57.20$38,381.20View SEC Filing  
6/1/2016David R GuyerCEOSell30,060$52.71$1,584,462.60View SEC Filing  
5/31/2016Samir Chandrakant PatelPresidentSell20,000$53.32$1,066,400.00View SEC Filing  
5/24/2016A/S NovoMajor ShareholderSell1,300,000$49.00$63,700,000.00View SEC Filing  
5/2/2016David R GuyerCEOSell22,060$46.18$1,018,730.80View SEC Filing  
4/29/2016Samir Chandrakant PatelPresidentSell20,000$46.79$935,800.00View SEC Filing  
4/1/2016David R GuyerCEOSell22,060$44.11$973,066.60View SEC Filing  
3/29/2016Samir Chandrakant PatelPresidentSell20,000$41.85$837,000.00View SEC Filing  
3/1/2016David R GuyerCEOSell22,060$45.48$1,003,288.80View SEC Filing  
2/29/2016Samir Chandrakant PatelPresidentSell20,000$45.13$902,600.00View SEC Filing  
1/29/2016Samir Chandrakant PatelPresidentSell20,000$53.59$1,071,800.00View SEC Filing  
1/28/2016David R. GuyerCEOSell18,598$53.63$997,410.74View SEC Filing  
1/11/2016Nicholas GalakatosDirectorSell3,000$65.72$197,160.00View SEC Filing  
1/4/2016Barbara A. WoodSVPSell1,000$76.37$76,370.00View SEC Filing  
12/30/2015David R. GuyerCEOSell18,582$78.82$1,464,633.24View SEC Filing  
12/30/2015Glenn SblendorioDirectorSell2,000$80.00$160,000.00View SEC Filing  
12/29/2015Samir Chandrakant PatelPresidentSell1,184$77.50$91,760.00View SEC Filing  
12/24/2015Samir Chandrakant PatelPresidentSell26,036$77.09$2,007,115.24View SEC Filing  
12/10/2015Nicholas GalakatosDirectorSell3,000$64.44$193,320.00View SEC Filing  
12/1/2015Barbara A. WoodSVPSell2,000$63.24$126,480.00View SEC Filing  
11/30/2015David R. GuyerCEOSell18,582$62.49$1,161,189.18View SEC Filing  
11/24/2015Samir Chandrakant PatelPresidentSell27,215$60.27$1,640,248.05View SEC Filing  
11/18/2015Nicholas GalakatosDirectorSell1,500$60.00$90,000.00View SEC Filing  
11/5/2015Samir Chandrakant PatelPresidentSell20,687$53.55$1,107,788.85View SEC Filing  
10/21/2015Samir Chandrakant PatelPresidentSell27,215$43.27$1,177,593.05View SEC Filing  
10/16/2015Barbara A. WoodSVPSell2,000$45.00$90,000.00View SEC Filing  
9/29/2015David R. GuyerCEOSell18,582$37.69$700,355.58View SEC Filing  
9/21/2015Samir Chandrakant PatelPresidentSell27,215$46.34$1,261,143.10View SEC Filing  
8/31/2015David R. GuyerCEOSell18,582$44.88$833,960.16View SEC Filing  
8/20/2015Samir Chandrakant PatelPresidentSell27,215$48.75$1,326,731.25View SEC Filing  
7/20/2015Samir Chandrakant PatelPresidentSell27,215$67.87$1,847,082.05View SEC Filing  
7/17/2015Glenn SblendorioDirectorSell3,000$67.33$201,990.00View SEC Filing  
7/1/2015Barbara A WoodSVPSell2,000$51.94$103,880.00View SEC Filing  
6/29/2015David R GuyerCEOSell18,582$51.05$948,611.10View SEC Filing  
6/18/2015Samir Chandrakant PatelPresidentSell12,000$49.78$597,360.00View SEC Filing  
5/28/2015David R GuyerCEOSell18,582$48.62$903,456.84View SEC Filing  
4/29/2015David R GuyerCEOSell18,582$48.45$900,297.90View SEC Filing  
4/17/2015Samir Chandrakant PatelPresidentSell12,000$50.47$605,640.00View SEC Filing  
3/30/2015Axel BolteDirectorBuy500$48.27$24,135.00View SEC Filing  
3/30/2015David R GuyerCEOSell18,582$48.26$896,767.32View SEC Filing  
3/2/2015Barbara A WoodSVPSell2,000$53.26$106,520.00View SEC Filing  
3/2/2015David R GuyerCEOSell18,582$53.22$988,934.04View SEC Filing  
1/2/2015David R GuyerCEOSell15,034$45.34$681,641.56View SEC Filing  
11/13/2014A/S NovoMajor ShareholderSell995,000$40.20$39,999,000.00View SEC Filing  
11/3/2014David R GuyerCEOSell15,034$39.71$597,000.14View SEC Filing  
10/2/2014David R GuyerCEOSell2,807$38.52$108,125.64View SEC Filing  
10/2/2014Samir Chandrakant PatelPresidentSell1,965$38.04$74,748.60View SEC Filing  
10/1/2014David R GuyerCEOSell12,227$37.30$456,067.10View SEC Filing  
10/1/2014Samir Chandrakant PatelPresidentSell17,676$37.28$658,961.28View SEC Filing  
9/4/2014David R GuyerCEOSell1,107$38.58$42,708.06View SEC Filing  
8/1/2014Bruce PeacockCFOSell6,191$37.78$233,895.98View SEC Filing  
8/1/2014David R GuyerCEOSell13,136$37.85$497,197.60View SEC Filing  
8/1/2014Samir Chandrakant PatelPresidentSell18,986$37.80$717,670.80View SEC Filing  
7/1/2014Bruce PeacockCFOSell7,739$41.07$317,840.73View SEC Filing  
7/1/2014David R GuyerCEOSell15,034$41.08$617,596.72View SEC Filing  
7/1/2014Samir Chandrakant PatelPresidentSell18,986$41.08$779,944.88View SEC Filing  
6/16/2014Nicholas GalakatosDirectorSell144,976$44.17$6,403,589.92View SEC Filing  
6/11/2014Lifesciences Ii L.P. ClarusMajor ShareholderSell211,680$45.42$9,614,505.60View SEC Filing  
6/4/2014Svlsf Iv, LlcMajor ShareholderSell1,966,935$42.54$83,673,414.90View SEC Filing  
6/3/2014Bruce PeacockCFOSell13,931$40.12$558,911.72View SEC Filing  
6/3/2014Svlsf Iv, LlcMajor ShareholderSell1,865,619$40.65$75,837,412.35View SEC Filing  
6/2/2014David R GuyerCEOSell25,417$39.92$1,014,646.64View SEC Filing  
6/2/2014Samir Chandrakant PatelPresidentSell27,873$39.91$1,112,411.43View SEC Filing  
5/30/2014Svlsf Iv, LlcMajor ShareholderSell931,869$40.99$38,197,310.31View SEC Filing  
5/28/2014Svlsf Iv, LlcMajor ShareholderSell980,127$40.19$39,391,304.13View SEC Filing  
5/23/2014Svlsf Iv, LlcMajor ShareholderSell330,450$38.10$12,590,145.00View SEC Filing  
5/13/2014Hbm Healthcare Investments (Camajor shareholderSell500,000$29.75$14,875,000.00View SEC Filing  
5/1/2014Bruce PeacockCFOSell4,643$32.43$150,572.49View SEC Filing  
5/1/2014David GuyerCEOSell10,665$33.71$359,517.15View SEC Filing  
5/1/2014Samir Chandrakant PatelPresidentSell14,319$32.45$464,651.55View SEC Filing  
3/24/2014Bruce PeacockCFOSell6,137$34.77$213,383.49View SEC Filing  
3/24/2014David GuyerCEOSell12,027$34.53$415,292.31View SEC Filing  
3/24/2014Samir Chandrakant PatelPresidentSell16,876$34.54$582,897.04View SEC Filing  
2/18/2014Svlsf Iv, Llcmajor shareholderSell2,111,364$29.61$62,517,488.04View SEC Filing  
9/30/2013A/S NovoInsiderBuy455,000$22.00$10,010,000.00View SEC Filing  
9/30/2013Hbm Healthcare Investments (CaMajor ShareholderBuy228,000$22.00$5,016,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Ophthotech Corporation (NASDAQ:OPHT)
DateHeadline
News IconCrown Castle to Present at the Deutsche Bank 25th Annual Media & Telecom Conference (NASDAQ:OPHT)
www.econotimes.com - February 23 at 7:08 PM
News IconArchrock, Inc. Reports Fourth-Quarter and Full-Year 2016 Results (NASDAQ:OPHT)
www.econotimes.com - February 23 at 9:16 AM
News IconBiosensing Instrument Inc Company Profile (NASDAQ:OPHT)
www.bioportfolio.com - February 22 at 7:09 PM
4-traders.com logoOPHTHOTECH CORP : Khang & Khang LLP Announces Securities Class Action Lawsuit .. (NASDAQ:OPHT)
www.4-traders.com - February 22 at 7:09 PM
finance.yahoo.com logoOPHT INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Ophthotech Corporation and a Lead Plaintiff Deadline of March 13, 2017 (NASDAQ:OPHT)
finance.yahoo.com - February 22 at 7:09 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Ophthotech Corporation To Contact The Firm Before Lead Plaintiff Deadline (NASDAQ:OPHT)
finance.yahoo.com - February 22 at 7:09 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Ophthotech Corporation, and Encourages Investors with Losses to Contact the Firm (NASDAQ:OPHT)
finance.yahoo.com - February 22 at 7:09 PM
News IconWhat Ophthotech Corporation (OPHT) And Its Chart Reveal Today - NY Stock News (NASDAQ:OPHT)
nystocknews.com - February 22 at 9:06 AM
businesswire.com logoOphthotech Corporation to Report Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call on ... - Business Wire (press release) (NASDAQ:OPHT)
www.businesswire.com - February 22 at 9:06 AM
finance.yahoo.com logoOphthotech Corporation to Report Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call on Tuesday, February 28, 2017 (NASDAQ:OPHT)
finance.yahoo.com - February 22 at 9:06 AM
News IconKiosk translating in sign language assist deaf customers and help restaurants reduce risk of ADA lawsuits (NASDAQ:OPHT)
www.econotimes.com - February 21 at 5:51 PM
businesswire.com logoINVESTOR COMPLAINT: Levi & Korsinsky, LLP Reminds Investors of Ophthotech Corporation of a Class Action ... - Business Wire (press release) (NASDAQ:OPHT)
www.businesswire.com - February 18 at 6:13 PM
4-traders.com logoScovill Fasteners : to Host its First Blood Drive of 2017 with the American Red Cross (NASDAQ:OPHT)
www.4-traders.com - February 18 at 11:46 AM
News IconAll-Star Lineup Comes to New Jersey Hall of Fame Induction Ceremony (NASDAQ:OPHT)
www.econotimes.com - February 18 at 11:46 AM
finance.yahoo.com logoOPHTHOTECH SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Ophthotech Corporation – (OPHT) (NASDAQ:OPHT)
finance.yahoo.com - February 18 at 11:46 AM
sbwire.com logoNew Market Study, "Wet Macular Degeneration Global Clinical Trials Review, H2, 2016", Has Been Published (NASDAQ:OPHT)
www.sbwire.com - February 17 at 4:43 PM
benzinga.com logoINVESTOR COMPLAINT: Levi & Korsinsky, LLP... (NASDAQ:OPHT)
www.benzinga.com - February 17 at 4:43 PM
News IconSmithfield Foods’ Helping Hungry Homes® Partners With Publix to Donate More Than 30,000 Pounds of Protein to Feeding South Florida (NASDAQ:OPHT)
www.econotimes.com - February 17 at 4:43 PM
finance.yahoo.com logoINVESTOR COMPLAINT: Levi & Korsinsky, LLP Reminds Investors of Ophthotech Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 (NASDAQ:OPHT)
finance.yahoo.com - February 17 at 4:43 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:OPHT)
finance.yahoo.com - February 17 at 4:43 PM
News IconSkyline Medical, Inc. Compliant with All Nasdaq Listing Criteria (NASDAQ:OPHT)
www.econotimes.com - February 17 at 8:16 AM
News IconWatching Shares of PennantPark Investment Corporation (PNNT) — Stock Focus (NASDAQ:OPHT)
eleganthomesinla.com - February 16 at 6:37 PM
baystreet.ca logoINVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and ... - Baystreet.ca (NASDAQ:OPHT)
www.baystreet.ca - February 13 at 8:58 PM
News IconTechnical Roundup on Shares of Ophthotech Corporation (OPHT) - Baldwin Journal (NASDAQ:OPHT)
baldwinjournal.com - February 13 at 8:58 PM
businesswire.com logoOPHT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving ... - Business Wire (press release) (NASDAQ:OPHT)
www.businesswire.com - February 13 at 8:58 PM
finance.yahoo.com logoOPHT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Ophthotech Corporation and a Lead Plaintiff Deadline of March 13, 2017 (NASDAQ:OPHT)
finance.yahoo.com - February 13 at 8:58 PM
finance.yahoo.com logoINVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:OPHT)
finance.yahoo.com - February 13 at 8:58 PM
News IconForward Earnings Estimate of Ophthotech Corporation(OPHT ... - Highland Mirror (NASDAQ:OPHT)
www.highlandmirror.com - February 11 at 1:02 AM
News IconOphthotech Corporation (NASDAQ:OPHT) Institutional Ownership stands at 90.2 - The Newburgh Press (NASDAQ:OPHT)
newburghpress.com - February 9 at 8:10 PM
News IconOphthotech Corporation (OPHT) Analyst Opinion And Outlook - Post Analyst (NASDAQ:OPHT)
postanalyst.com - February 9 at 1:03 AM
News IconOphthotech Corporation (NASDAQ:OPHT) has 1 year Price Target of $8.13 - The Newburgh Press (NASDAQ:OPHT)
newburghpress.com - February 9 at 1:03 AM
globenewswire.com logoOPHT INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Ophthotech ... - GlobeNewswire (press release) (NASDAQ:OPHT)
globenewswire.com - February 9 at 1:03 AM
forbes.com logoEarnings Preview: What To Expect From Regeneron On Thursday (NASDAQ:OPHT)
www.forbes.com - February 8 at 7:58 PM
businesswire.com logoDEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In ... (NASDAQ:OPHT)
www.businesswire.com - February 8 at 7:58 PM
finance.yahoo.com logoOPHT INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Ophthotech … (NASDAQ:OPHT)
finance.yahoo.com - February 8 at 7:58 PM
finance.yahoo.com logoDEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Ophthotech Corporation To Contact The Firm (NASDAQ:OPHT)
finance.yahoo.com - February 8 at 7:58 PM
finance.yahoo.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Ophthotech Corporation, and Encourages Investors with Losses to Contact the Firm (NASDAQ:OPHT)
finance.yahoo.com - February 8 at 7:58 PM
feeds.benzinga.com logoOPHT INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Ophthotech Corporation and a Lead Plaintiff Deadline of March 13, 2017 (NASDAQ:OPHT)
feeds.benzinga.com - February 8 at 3:26 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ophthotech Corporation (OPHT) & Lead Plaintiff Deadline - March 13, 2017 (NASDAQ:OPHT)
us.rd.yahoo.com - February 8 at 1:12 AM
globenewswire.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ophthotech ... - GlobeNewswire (press release) (NASDAQ:OPHT)
globenewswire.com - February 7 at 8:07 PM
News IconOphthotech Corporation (NASDAQ:OPHT) hit its 52 Week high of $65.96 on Jul 28, 2016 - The Newburgh Press (NASDAQ:OPHT)
newburghpress.com - February 7 at 9:05 AM
globenewswire.com logoSHAREHOLDER COMPLAINT: Levi & Korsinsky, LLP Reminds Investors of Ophthotech Corporation of ... - GlobeNewswire (press release) (NASDAQ:OPHT)
globenewswire.com - February 4 at 7:04 PM
benzinga.com logoOPHTHOTECH SHAREHOLDER ALERT BY FORMER LOUISIANA... (NASDAQ:OPHT)
www.benzinga.com - February 4 at 12:52 AM
finance.yahoo.com logoOPHTHOTECH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK ... (NASDAQ:OPHT)
finance.yahoo.com - February 4 at 12:52 AM
finance.yahoo.com logoEQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm (NASDAQ:OPHT)
finance.yahoo.com - February 3 at 7:50 PM
feeds.benzinga.com logoSHAREHOLDER COMPLAINT: Levi & Korsinsky, LLP Reminds Investors of Ophthotech Corporation of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017 (NASDAQ:OPHT)
feeds.benzinga.com - February 3 at 12:49 PM
investopedia.com logoOphthotech Mulls Options, Revamps Management (OPHT) - Investopedia (NASDAQ:OPHT)
www.investopedia.com - February 2 at 7:58 PM
streetinsider.com logoOphthotech Corp (OPHT) to Review Strategic Alternatives; Hires Leerink Partners - StreetInsider.com (NASDAQ:OPHT)
www.streetinsider.com - February 2 at 7:58 PM
investopedia.com logoOphthotech Hires Adviser, Mulls Strategic Options (NASDAQ:OPHT)
www.investopedia.com - February 2 at 7:58 PM
News IconOphthotech (OPHT) Eyeing Strategic Options (NASDAQ:OPHT)
galaxystocks.com - February 2 at 1:13 AM

Social

What is Ophthotech Corporation's stock symbol?

Ophthotech Corporation trades on the NASDAQ under the ticker symbol "OPHT."

Where is Ophthotech Corporation's stock going? Where will Ophthotech Corporation's stock price be in 2017?

12 equities research analysts have issued 1 year target prices for Ophthotech Corporation's shares. Their forecasts range from $11.00 to $92.00. On average, they anticipate Ophthotech Corporation's share price to reach $59.11 in the next year.

When will Ophthotech Corporation announce their earnings?

Ophthotech Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, February, 28th 2017.

Who owns Ophthotech Corporation stock?

Ophthotech Corporation's stock is owned by a number of of institutional and retail investors. Top institutional investors include Stonepine Capital Management LLC (6.42%), State Street Corp (4.36%), Tourbillon Capital Partners L.P. (3.81%), Bogle Investment Management L P DE (3.58%), Fiera Capital Corp (2.54%) and Guggenheim Capital LLC (1.17%). Company insiders that own Ophthotech Corporation stock include A/S Novo, Axel Bolte, Barbara A Wood, David R Guyer, Glenn Sblendorio, Henric Bjorn Bjarke, Nicholas Galakatos and Samir Chandrakant Patel.

Who bought Ophthotech Corporation stock? Who is buying Ophthotech Corporation stock?

Ophthotech Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Tourbillon Capital Partners L.P., Bogle Investment Management L P DE, State Street Corp, Guggenheim Capital LLC, Numeric Investors LLC, Quinn Opportunity Partners LLC and Fiera Capital Corp.

How do I buy Ophthotech Corporation stock?

Shares of Ophthotech Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Ophthotech Corporation stock cost?

One share of Ophthotech Corporation stock can currently be purchased for approximately $4.26.

Ophthotech Corporation (NASDAQ:OPHT) Chart for Friday, February, 24, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Ophthotech Corporation (NASDAQ:OPHT)

Earnings History Chart

Earnings by Quarter for Ophthotech Corporation (NASDAQ:OPHT)

Dividend History Chart

Dividend Payments by Quarter for Ophthotech Corporation (NASDAQ:OPHT)

Last Updated on 2/24/2017 by MarketBeat.com Staff